Avantor Inc
NYSE:AVTR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18.32
27.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AVTR stock under the Base Case scenario is 25.106 USD. Compared to the current market price of 22.755 USD, Avantor Inc is Undervalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Avantor Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AVTR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Avantor Inc. is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology sectors. Founded in 1904, the company has evolved from a small laboratory supply provider to a vital player in the biotechnology, pharmaceuticals, and diagnostics industries. With a portfolio of more than 10 million high-quality products, Avantor supports research and manufacturing needs across various environments, helping scientists and engineers push the boundaries of innovation. The firm prides itself on its commitment to sustainability and operational excellence, emphasizing an integrated supply chain that ensures reliable delivery and unmatched s...
Avantor Inc. is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology sectors. Founded in 1904, the company has evolved from a small laboratory supply provider to a vital player in the biotechnology, pharmaceuticals, and diagnostics industries. With a portfolio of more than 10 million high-quality products, Avantor supports research and manufacturing needs across various environments, helping scientists and engineers push the boundaries of innovation. The firm prides itself on its commitment to sustainability and operational excellence, emphasizing an integrated supply chain that ensures reliable delivery and unmatched service.
As an investor, understanding Avantor’s strategic positioning in a growing industry is crucial. With increasing global healthcare demands and rising investments in research and development, Avantor stands to benefit from the burgeoning life sciences market. The company's focus on digital transformation and efficiency improvements enhances its operational capabilities, while its strategic acquisitions have broadened its offerings and market reach. Furthermore, Avantor's consistent revenue growth and robust financial performance showcase a resilient business model, making it a compelling investment opportunity for those looking to capitalize on the future of scientific progress and innovation.
Avantor Inc. operates primarily in the life sciences and advanced technology sectors, providing a range of products and services that cater to various industries. Here are the core business segments of Avantor:
-
Life Sciences:
- This segment offers a wide array of supplies and services used in laboratory research, including reagents, cell culture media, and consumables for pharmaceutical development and manufacturing. Avantor supports industries such as biotechnology, pharmaceuticals, and academic research institutions.
-
Advanced Technologies & Applied Materials:
- This part of the business focuses on high-purity materials and specialty chemicals used in the manufacturing processes of electronics, optics, and other advanced technology sectors. It includes products necessary for semiconductor manufacturing and other applications requiring precision and high purity.
-
Chemicals and Supplies:
- Avantor provides various chemicals, solvents, and materials needed for research and industrial applications. This includes raw materials for manufacturing and specialized chemicals used in various research disciplines.
-
Bioprocessing:
- This is a specialized area dealing with the production of biological products, such as monoclonal antibodies and vaccines. Avantor supplies the necessary materials and services for bioprocessing facilities, supporting clients from early development to commercialization.
-
Customer Solutions:
- Avantor emphasizes tailored customer support and solutions, helping clients optimize their processes and ensure compliance throughout their operations. This includes consultative services and logistics solutions designed to enhance efficiency and reduce costs.
Overall, Avantor Inc. positions itself as a global leader in providing essential products and services to support scientific research and the development of life-changing therapies and technologies across multiple industries.
Avantor Inc., a global provider of avant-garde consumables and services for the life sciences and advanced technologies sectors, holds several unique competitive advantages over its rivals:
-
Broad Product Portfolio: Avantor offers a comprehensive range of products, including laboratory supplies, reagents, and customized services. This extensive portfolio enables it to serve diverse customer needs and capture market share across various segments, reducing reliance on a single product line.
-
Strong Brand Reputation: Avantor has built a strong reputation for quality, reliability, and innovation in the scientific community. This brand equity fosters customer loyalty and can be difficult for new entrants to replicate.
-
Global Reach: With operations in over 30 countries, Avantor has a solid global footprint. This allows them to cater to international customers and navigate regional regulations effectively, giving them an edge in markets where local presence is crucial.
-
Customized Solutions: Avantor focuses on providing tailored solutions to customers, which can enhance customer satisfaction and retention. This customer-centric approach, combined with their technical expertise, positions them favorably in the market.
-
Strong Supply Chain Management: Avantor leverages advanced logistics and inventory management systems to ensure timely delivery and minimize disruptions. A robust supply chain can significantly enhance customer trust and repeat business.
-
Investment in Innovation: Avantor emphasizes research and development to stay ahead of industry trends and technological advancements. This commitment to innovation enables them to launch new products that meet emerging market needs more quickly than their competitors.
-
Strategic Partnerships and Acquisitions: Avantor has actively pursued strategic partnerships and acquisitions to enhance its capabilities and expand its market presence. These strategies can lead to increased synergies, enhanced offerings, and a stronger market position.
-
Expertise in Regulated Markets: The company has considerable experience in highly regulated markets, such as pharmaceuticals and biotechnology. This expertise allows Avantor to navigate regulatory challenges effectively, a significant barrier for many competitors.
-
Sustainability Initiatives: With increasing customer focus on sustainability, Avantor's commitment to environmental stewardship can be a strong differentiator. Their initiatives in sustainable practices can enhance their appeal to eco-conscious customers.
By leveraging these competitive advantages, Avantor can effectively differentiate itself from rivals and maintain a strong position in the highly competitive life sciences and advanced technology markets.
Avantor Inc., a global supplier of ultra-high-purity materials and customized solutions for the life sciences and advanced technology industries, faces several risks and challenges in the near future:
-
Supply Chain Disruptions: As a provider of critical materials, Avantor is susceptible to global supply chain issues. Disruptions due to geopolitical tensions, pandemics, or natural disasters can significantly impact their operations and ability to meet customer demand.
-
Increasing Competition: The life sciences and advanced materials sectors are competitive, with numerous companies emerging as potential rivals. Avantor must continuously innovate and improve its offerings to maintain market share and pricing power.
-
Regulatory Compliance: The industry is heavily regulated, with ongoing changes in guidelines and regulations. Ensuring compliance with varying international regulations (such as FDA, EMA, etc.) presents both an operational challenge and a risk of potential penalties.
-
Rising Costs: Increases in raw material costs, labor expenses, and transportation costs can pressure margins. Avantor needs to manage these cost increases while remaining competitive in pricing.
-
Technological Advancements: The rapid pace of technological change could render some of Avantor’s products or processes obsolete. Keeping up with innovation and investing in R&D is critical to staying relevant.
-
Market Demand Fluctuations: Demand in the biotech and pharmaceutical sectors can vary based on economic conditions, research funding, and market trends. A downturn in any major market segment could adversely affect revenue.
-
Customer Concentration: Avantor may have significant sales from a relatively small number of large customers. Loss of any key customer or shift in their purchasing behavior could have a considerable financial impact.
-
Talent Retention and Acquisition: The need for skilled professionals in life sciences and materials science means that Avantor faces challenges in attracting and retaining top talent, which is crucial for innovation and service delivery.
-
Environmental, Social, and Governance (ESG) Factors: Growing emphasis on sustainability can pose challenges in terms of compliance and reputation. Avantor must align with ESG criteria to meet customer expectations and regulatory requirements.
-
Litigation Risks: As with many companies in the life sciences sector, Avantor is exposed to potential litigation related to product liability, patent disputes, or regulatory challenges, which can result in financial losses or reputational damage.
Mitigating these risks will require strategic planning, robust risk management strategies, and an ongoing commitment to innovation and customer satisfaction.
Revenue & Expenses Breakdown
Avantor Inc
Balance Sheet Decomposition
Avantor Inc
Current Assets | 2.5B |
Cash & Short-Term Investments | 285.3m |
Receivables | 1.1B |
Other Current Assets | 1.1B |
Non-Current Assets | 10.3B |
PP&E | 722.8m |
Intangibles | 9.2B |
Other Non-Current Assets | 419.8m |
Current Liabilities | 1.6B |
Accounts Payable | 673.5m |
Accrued Liabilities | 223.2m |
Other Current Liabilities | 733.1m |
Non-Current Liabilities | 5.7B |
Long-Term Debt | 4.7B |
Other Non-Current Liabilities | 966.2m |
Earnings Waterfall
Avantor Inc
Revenue
|
6.8B
USD
|
Cost of Revenue
|
-4.5B
USD
|
Gross Profit
|
2.3B
USD
|
Operating Expenses
|
-1.7B
USD
|
Operating Income
|
630m
USD
|
Other Expenses
|
-320.4m
USD
|
Net Income
|
309.6m
USD
|
Free Cash Flow Analysis
Avantor Inc
USD | |
Free Cash Flow | USD |
AVTR Profitability Score
Profitability Due Diligence
Avantor Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Avantor Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
AVTR Solvency Score
Solvency Due Diligence
Avantor Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Avantor Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AVTR Price Targets Summary
Avantor Inc
According to Wall Street analysts, the average 1-year price target for AVTR is 28.423 USD with a low forecast of 20.2 USD and a high forecast of 35.7 USD.
Dividends
Current shareholder yield for AVTR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Contact
IPO
Employees
Officers
The intrinsic value of one AVTR stock under the Base Case scenario is 25.106 USD.
Compared to the current market price of 22.755 USD, Avantor Inc is Undervalued by 9%.